Document is current
Any future updates will be listed below
-
Authors
Welter, Danielle https://orcid.org/0000-0003-1058-2668
Juty, Nick https://orcid.org/0000-0002-2036-8350
Rocca-Serra, Philippe https://orcid.org/0000-0001-9853-5668
Xu, Fuqi https://orcid.org/0000-0002-5923-3859
Henderson, David https://orcid.org/0000-0002-6433-200X
Gu, Wei https://orcid.org/0000-0003-3951-6680
Strubel, Jolanda https://orcid.org/0000-0001-6675-4639
Giessmann, Robert T. https://orcid.org/0000-0002-0254-1500
Emam, Ibrahim https://orcid.org/0000-0002-7561-2787
Gadiya, Yojana https://orcid.org/0000-0002-7683-0452
Abbassi-Daloii, Tooba https://orcid.org/0000-0002-4904-3269
Alharbi, Ebtisam https://orcid.org/0000-0002-3887-3857
Gray, Alasdair J. G. https://orcid.org/0000-0002-5711-4872
Courtot, Melanie https://orcid.org/0000-0002-9551-6370
Gribbon, Philip https://orcid.org/0000-0001-7655-2459
Ioannidis, Vassilios https://orcid.org/0000-0002-4209-2578
Reilly, Dorothy S. https://orcid.org/0000-0002-6677-3132
Lynch, Nick https://orcid.org/0000-0002-8997-5298
Boiten, Jan-Willem https://orcid.org/0000-0003-0327-638X
Satagopam, Venkata https://orcid.org/0000-0002-6532-5880
Goble, Carole https://orcid.org/0000-0003-1219-2137
Sansone, Susanna-Assunta https://orcid.org/0000-0001-5306-5690
Burdett, Tony https://orcid.org/0000-0002-2513-5396
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
Innovative Medicines Initiative (802750)
- License Information
-
More Information
Article History
Received: 14 October 2022
Accepted: 28 March 2023
First Online: 19 May 2023
Competing interests
: SAS is Honorary Academic Editor of <i>Scientific Data</i> and PRS is a member of the <i>Scientific Data</i> Senior Editorial Board.
